84 - Parvimonas MICRA 512 Promotes Intestinal Tumorigenesis in Germ-Free and Conventional APCMIN/+ Mice

Liuyang Zhao,Risheng Zhao,Xiaohang Long,Olabisi O. Coker,William K. Wu,Sunny Wong,Francis K. Chan,Ka Fai To,Jun Yu
DOI: https://doi.org/10.1016/s0016-5085(18)30560-2
2020-01-01
Abstract:Background:Large-scale meta-analysis of fecal shotgun metagenomic sequences revealed high abundance of Parvimonas micra in colorectal cancer (CRC) patients. We investigated the role of P. micra in colon tumorigenesis.Results: P. micra was significantly enriched in 128 stool samplesfrom CRC patients compared with 181 samples from healthy controls(p<0.0001) and in 52 pairedtissue biopsies from CRC patientsthan 61 samples from healthy individuals (p<0.05). P. micra strain 512 was isolated from the feces of a CRC patient.Colon cell lines exposed to P. micra- conditioned medium significantly increased cell proliferation.Apcmin/+ mice gavaged with P. micra exhibited significantly higher tumor burden and load (both p<0.01). Consistently, cell proliferation was significantly higher in the colon tissues of germ-free mice gavaged with P. micraevidenced by increased Ki-67-positive cells and PCNA protein expression. Th2 and Th17 cells were markedly increased, while Th1 cells were reduced in the lamina propria of the colon tissues of mice gavaged with P. micra (all p<0.01). Moreover, P. micra colonization in germ-free mice was associated with increased expression of pro-inflammatory cytokines including Tnf-α, Il17a, Il6 and Cxcr1.Conclusions: P. micra promoted intestinal carcinogenesis in Apcmin/+ mice and increased cell proliferation in germ-free mice. The tumor-promoting effect of P. micra was associated with altered immune responses and enhanced inflammation in the gut.
What problem does this paper attempt to address?